Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
RARE | Ultragenyx Pharmaceutical Inc. | EVP and Chief Medical Officer | $2.11 M | -$88.3 K | -4.01% | May 2, 2024 |
Sym | Company | Class | Transaction | % | Value $ | Price $ | Shares | Shares After | Date | Ownership |
---|